Dr David Johnson comments on the American Cancer Society's projections for colorectal cancer in 2024.
-- TRANSCRIPT -- Hello. I'm Dr David Johnson, professor of medicine and chief of gastroenterology at Eastern Virginia Medical School in Norfolk, Virginia.
The American Cancer Society has just published its cancer statistics for 2024. This is an annual report, the latest version of which has some alarming news for gastroenterologists. Usually, we think of being "number one" as a positive thing, but that's not the case this year when it comes to the projections for colorectal cancer.
But first, let's discuss the report's overall findings. Broadly speaking, the news is quite good in that there's been an aversion of over 4 million deaths since 1991. That decline over the past four decades is due to reductions in smoking, earlier detection, and improved screening and treatments for localized or metastatic disease. But these gains are now threatened by some offsets that we're seeing, with increasing rates of six of the top 10 cancers in the past several years.
Increasing Rates of Gastrointestinal Cancers The incidence rate of pancreas cancer has increased from 0.6% to 1% annually.
Pancreas cancer has a 5-year relative survival rate of 13%, which ranks as one of the three worst rates for cancers. This cancer represents a real screening challenge for us, as it typically presents asymptomatically.
Women have experienced a 2%-3% annual increase in incidence rates for liver cancer.
I suspect that this is due to cases of fibrotic liver disease resulting from viral hepatitis and metabolic liver diseases with nonalcoholic fatty liver and advanced fibrosis (F3 and F4). These cases may be carried over from before, thereby contributing to the increasing incremental cancer risk.
We can't overlook the need for risk reduction here and should focus on applying regular screening efforts in our female patients. However, it's also true that we require better liver cancer screening tests to accomplish that goal.
In Those Under 50, CRC the Leading Cause of Cancer Death in Men, Second in Women I really want to focus on the news around colorectal cancer.
To put this in perspective, in the late 1990s, colorectal cancer was the fourth leading cause of death in men and women. The current report extrapolated 2024 projections using the Surveillance, Epidemiology, and End Results (SEER) database ending in 2020, which was necessary given the incremental time it takes to develop cancers. The SEER database suggests that in 2024, colorectal cancer in those younger than 50 years of age will become the number-one leading cause of cancer death in men and number-two in women. The increasing incidence of colorectal cancer in younger people is probably the result of a number of epidemiologic and other reasons.
The current report offers evidence of racial disparities in cancer mortality rates in general, which are twofold higher in Black people compared with White people, particularly for gastric cancer. There is also an evident disparity in Native Americans, who have higher rates of gastric and liver cancer. This is a reminder of the increasing need for equity to address racial disparities across these populations.
But returning to colon cancer, it's a marked change to go from being the fourth-leading cause of cancer death in those younger than 50 years of age to being number one for men and number two for women.
Being "number one" is supposed to make you famous. This "number one," however, should in fact be infamous. It's a travesty, because colorectal cancer is a potentially preventable disease.
As we move into March, which happens to be Colorectal Cancer Awareness Month, hopefully this fires up some of the conversations you have with your younger at-risk population, who may be reticent or resistant to colorectal cancer screening.
We have to do better at getting this message out to that population at large. "Number one" is not where we want to be for this potentially preventable problem. #health
Hello, I'm Dr. David Johnson, Professor of Medicine and Chief of Gastroenterology at
Eastern Virginia Medical School in Norfolk, Virginia.
Well, the American Cancer Society has just published the Cancer Statistics for 2024.
This is an annualized report and it has some alarming features as it relates to gastroenterology.
And being number one is supposed to be good news.
We're number one and that's not good news.
I'll come back to that as it relates to colon cancer.
So let's discuss what they report.
Well, the good news is, and I'm going to focus only on the GI cancers in particular, but
the good news is a broad brush, is there has been a version of over four million deaths
since 1991.
So in the last four decades, we've seen as it relates to the potential reduction.
Why is that?
Because of cancers in general, there's reductions in smoking, there are reductions due to earlier
detection screening and improved screening and improved treatments for localized or metastatic
disease.
But these gains are threatened now by some offsets that we're seeing increasing in six
of the top cancers in the last several years have increased.
I'm going to again focus on GI here, but the gastrointestinal cancers relates to pancreas
cancer.
It's 0.6 to 1% increased annually.
This is a cancer now that ranks in the top three of the worst as it relates to five-year
survival down to 13%.
And in particular, this is something that we do see as a real challenge to screening
in particular for cancer that presents typically with symptoms or signs rather than asymptomatic.
As it relates to the liver cancers, there's a 2% to 3% annualized increase in liver cancers,
particularly in women.
What we're seeing, I suspect, is more carry forward of the fibrotic liver disease dating
back to the viral hepatitis and the metabolic liver diseases with non-alcoholic fatty liver
and advanced fibrosis, F3 and F4, as we're seeing carry forward, are now starting to
emerge with incremental cancer risk and particularly we need to not subject or let our risk reduction
profile down and really focus on screening these people very, very regularly.
We still need some better tests in liver cancer screening.
What I really want to focus on is colorectal cancer.
So just to put in perspective, in the late 1990s, colorectal cancer was the fourth leading
cause of death in men and women.
In the current data, and again, this is extrapolation using a 2020 database, again, they used the
SEER database in this particular construct, constructing it going to 2024 because of the
incremental time it takes to develop cancers.
This SEER database suggests that if we prospectively look at 2024, colorectal cancer in younger
than 50 becomes, as far as leading cause of death in men, number one, and women, number
two.
Again, we went from fourth, seeing a decrease in colorectal cancer and colorectal cancer
deaths in people over the age of 50, now in the younger population for lots of reasons
for the epidemiologic than that, but number one in men, number two in women.
There's also evidence from this current report that there's disparities that relate to racial
disparities.
The mortality rates are two-fold higher in black people compared to whites, in particular
as it relates to gastric cancer.
In Native Americans, the disparity is also evident for gastric and liver cancer.
So again, increased need for equity and racial disparities across these populations.
But coming back to colon cancer, we went from number four in the 90s for younger than 50,
and now we're number one for men, number two for women.
This is a travesty.
Number one is supposed to make you famous.
This, in fact, is infamous, and it's a travesty because it's a potentially preventable disease.
As we move into colorectal cancer awareness month of March, hopefully this fires up some
of the conversations you have with your younger population that may be reticent or resistant
to colorectal cancer screening.
We clearly need to get this message out to that population at large because we have to
do better.
Number one is not where we want to be in this disease for potential preventable problem.
Dr. David Johnson, hopefully this inspires you to have these conversations with your
population in general, but in particular focus on these younger populations at risk.
Thanks again for listening.